Home
Conditions
Lung Fibrosis

Clinical trial condition

Lung Fibrosis

Explore clinical trials studying Lung Fibrosis. Study availability and eligibility vary by location and protocol.

10 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Lung Fibrosis trial results

Recruiting

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

NCT06751069

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +6 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

University of Minnesota Minneapolis, Minnesota, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study

NCT07236541

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +5 more
Locations: Zhongshan hospital Shanghai, China

View Trial Details

Recruiting

Pulmonary Fibrosis Foundation Community Registry

NCT05382572

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, +7 more
Locations: Pulmonary Fibrosis Foundation Chicago, Illinois, United States

View Trial Details

Recruiting

Immune Modulation by Exosomes in COVID-19

NCT05191381

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +23 more
Locations: Ulm University Hospital, Clinic of Anesthesiology and Intensive Care Medicine Ulm, Germany

View Trial Details

Recruiting

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

NCT06189820

Conditions: FAP, Fibrosis, Idiopathic Pulmonary Fibrosis, +7 more
Locations: Medecine Brussels, Belgium

View Trial Details

Not Yet Recruiting

FAPI PET Imaging - An Exploratory Study

NCT07705074

Conditions: Adenocarcinoma, Adenoma, Blood Protein Disorders, +80 more
Locations: Kantonsspital Baden Baden, Canton of Aargau, Switzerland

Hôpitaux Universitaires de Genève (HUG) Geneva, Canton of Geneva, Switzerland

Luzerner Kantonsspital Lucerne, Canton of Lucerne, Switzerland

Clinique de Genolier Genolier, Canton of Vaud, Switzerland

View Trial Details

Completed

Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease

NCT01570764

Conditions: Connective Tissue Diseases, Fibrosis, Interstitial Lung Disease, +13 more
Locations: Cochin Hospital Paris, France

View Trial Details

Completed

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

NCT05648734

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +20 more
Locations: Mansoura University Al Mansurah, Dakahlia Governorate, Egypt

View Trial Details

Completed

A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis

NCT04274257

Conditions: Autoimmune Diseases, Collagen Diseases, Connective Tissue Diseases, +13 more
Locations: University of Fukui Hospital Fukui, Japan

Chukyo Hospital Nagoya, Japan

The University of Tokyo Hospital Tokyo, Japan

University of Tsukuba Hospital Tsukuba, Japan

View Trial Details

Active, Not Recruiting

Pulmonary Outcomes on Patients With Lung Fibrosis

NCT07088185

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +5 more
Locations: South valley university Qina, Egypt

View Trial Details

Lung Fibrosis

Lung Fibrosis trial results

Related conditions